Episode 95: Exclusive Interview With $GHG/Global Hemp Group: New Headways in Cancer Treatment with Apollon Deal

Global Hemp Group (CSE: GHG | OTC: GBHPF | FRA: GHG) President and CEO Curt Huber and Special Medical Advisor Dr. Stephen Barnhill joins Global One Media to lay out the brand new frontiers the company looks to surpass year, including the recent groundbreaking deal reached with Apollon Formularies PLC that is opening a new direction for GHG into medical innovation. Dr. Barnhill, the research pioneer behind Apollon, discusses the exciting possibilities presented by natural biologics for effective treatments including in anti-cancer applications as well as the operational framework to carry out the program. Huber also outlines positive prospects for the company's valuation over the course of the venture. Learn more about Global Hemp Group: https://globalhempgroup.com